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under the CC BY-NC-ND license (http:Abstract A peritoneal dialysis patient with cirrhosis presented with drowsiness, vomiting,
and mild hyponatremia. Despite no active correction of hyponatremia, she developed convul-
sion and quadriplegia. Magnetic resonance imaging of the brain showed changes of osmotic
demyelination syndrome. This case illustrates that osmotic demyelination syndrome may occur
in peritoneal dialysis without rapid correction of hyponatremia.
本個案是一位腹膜透析的早期肝硬化病者, 因嗜睡和嘔吐住院, 血鈉輕度降低, 儘管沒有糾正低鈉
血症, 兩天後出現抽搐和四肢癱瘓。MRI顯示滲透性脱髓鞘綜合症的變化。本個案說明滲透性脱髓
鞘综合症可能在沒有急劇提升血鈉的腹膜透析病人中出現。Introduction
Osmotic demyelination syndrome (ODS) was most
commonly reported after over-rapid correction of hypona-
tremia. It is uncommon in peritoneal dialysis patients. We
report a case of peritoneal dialysis with ODS not associated
with rapid correction of plasma sodium.
Case report
Madam C was a 50-year-old diabetic nephropathy patient
treated with continuous ambulatory peritoneal dialysis. She
had early cirrhosis due to hepatitis B but was a teetotaler.
She was admitted for dizziness on July 5, 2013 and
vomited undigested food once. There was no fever, diar-
rhea, nor abdominal pain. Her Glasgow Coma Score (GCS)
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blood pressure of 210/120 mmHg. She had mild ankle
edema but her jugular venous pressure was not elevated.
Three hours after admission, she developed generalized
toniceclonic convulsion which was aborted with intrave-
nous diazepam after 3 minutes. Her temperature rose to
37.9C. Her white cell count was 5.8  109/L. Her plasma
sodium was 130 mmol/L. Her plasma potassium, calcium,
phosphate, glucose, urea, and creatinine were 4.9 mmol/L,
2.28 mmol/L, 2.46 mmol/L, 5.6 mmol/L, 23 mmol/L, and
895 mmol/L, respectively. She had normal liver function
tests and plasma ammonia level. Chest X-ray showed
bilateral lower zone infiltration. Plain-computed tomogra-
phy (CT) brain scan was unremarkable. Cerebrospinal fluid
(CSF) protein was 0.5 g/L. CSF white cell count, glucose,
Gram stain, ZiehleNeelsen stain, and Indian ink stain were
unremarkable. She was given intravenous phenytoin,
acyclovir, ceftriaxone, sulperazon, and labetalol. Her
hyponatremia was mild, and hypertonic saline was not
administered. On Day 2, her GCS improved to 14. Her blood
pressure was 187/108 mmHg. On Day 3, bedside electro-
encephalogram showed slow background waves with ahed by Elsevier (Singapore) Pte Ltd. This is an open access article
by-nc-nd/4.0/).
2 H.M. Cheng, S.H. Litriphasic pattern compatible with metabolic or toxic en-
cephalopathy. Intravenous valproate was added.
On Day 4, her GCS dropped to 8. She had no spontaneous
limb movement but had bilateral brisk jerk, bilateral
upgoing plantar reflexes, or bilateral ankle clonus. She was
intubated for suspected status epilepticus. Intravenous
propofol and levetiracetam were administered. Plain CT
brain scan was repeated but was unrevealing. Electroen-
cephalogram on Day 5 again showed triphasic pattern
without ictal discharge. Cytology and polymerase chain
reaction (PCR) of CSF for mycobacteria, herpes simplex
virus, herpes zoster virus, and enterovirus were negative.
Syphilis and Japanese B encephalitis serology were nega-
tive. Lead, manganese, and mercury levels in the blood
were not elevated.
Magnetic resonance imaging (MRI) of the brain on Day 14
revealed T2 weighted hyperintensities and T1 weighted
hypointensities in the central pons with sparing of periph-
eral tracts (Figure 1). The diagnosis was osmotic demye-
lination syndrome. She remained severely disabled and
succumbed to sepsis 1 year later.Discussion
We described a peritoneal dialysis patient with encepha-
lopathy. Encephalitis may present similarly but was
excluded by the CSF findings and negative serology and PCR
tests for common infectious etiologies. Lead, mercury, and
manganese poisoning were not supported by the blood
levels. The MRI appearance, particularly the sparing of the
peripheral tracts in the central pons, made osmotic
demyelination syndrome more likely than pontine
infarction.
The syndrome was previously named central pontine
demyelinolysis. Adams et al1 reported four cases with
alcoholism and malnutrition developing quadriplegia and
pseudobulbar palsy. Autopsy showed symmetrical loss of
myelin in the central pons. They postulated that the cause
was a toxin or nutritional deficiency. Within a number of
years, extrapontine lesions involving cerebellar peduncles,
lateral geniculate nuclei, thalamus, basal ganglia, andFigure 1 (A) Hypointense pontine lesion on T1 flair imamidbrain were found, either alone or with the pontine le-
sions. With advances in neuroimaging, the diagnosis was not
as rare as once thought. An incidence of 3/1000 of unse-
lected urban hospital population was reported.2
Tomlinson et al3 discovered the association of rapid
correction of hyponatremia and ODS. Laureno4 rapidly
corrected severe hyponatremia in dogs and reproduced the
lesions. The syndrome did not occur when hyponatremia
was corrected in a rate less than 10 mmol/L/day. It was
postulated that abrupt osmotic changes lead to apoptosis of
astrocytes, disrupting the blood brain barrier and allowing
entry of myelinotoxic components like complements to
cause demyelination. As the myelinolytic factors originate
from the more vascular gray matter, areas where white and
grey matter intermix (e.g. central pons) are more prone to
the lesions.5,6 Our patient had plasma sodium of
127e130 mmol/L. However, her sodium level was not
rapidly corrected. She had early hepatitis B cirrhosis,
another established predisposing factor for ODS.7 Uremia
was thought to protect against ODS.8,9 Nevertheless, Tar-
han et al10 reported 17 renal failure patients with ODS.
Hyponatremia and dialysis disequilibrium syndrome were
present in 47% and 24% of this series. The initial encepha-
lopathy of our patient improved but later deteriorated
again.11 This biphasic pattern is also typical of ODS.
Though CT brain may reveal hypodense pontine lesions,
the sensitivity is low because of beam hardening artifact.
Diffusion weighted imaging (DWI) is more sensitive. Evi-
dence of diffusion restriction like increased DWI signals and
decreased apparent coefficient of diffusion values may
appear in the central pons in a “trident pattern” within 24
hours of clinical onset. The changes improve significantly
within the 1st week and revert to baseline in 3e4 weeks. T2
weighted hyperintensities in a “trident pattern” take 2
weeks to appear in the central pons.12 The volume and
distribution of T2 signal abnormalities does not correlate
with clinical severity and outcome.13 As symptoms resolve,
the size and intensity of T2 abnormalities decrease. The
classical “trident pattern” in DWI and T2 images is due to
sparing of peripheral fibers and the axons of corticospinal
tracts.12 T1 signal hypointensities may occur in acute set-
tings but are unreliable. Gadolinium enhancement isge and (B) hyperintense lesion on T2 weighted image.
A peritoneal dialysis patient with ODS 3atypical but may occur in the periphery in a minority of
cases. MRI abnormalities of ODS may occur in other regions
like the cerebellum, lateral geniculate body, external
capsule, thalamus, basal ganglia, the greyewhite junction
of the cerebral cortex, and hippocampi.
ODS can be prevented by avoiding over-rapid correction
of hyponatremia.4 Relowering of plasma sodium14 and
minocycline15 prevented ODS in rat models. Treatment
after the onset of ODS has not been established. Relowering
of plasma sodium was effective in rat models and one case
report.16 Plasmapharesis to remove the myelinotoxic com-
ponents was useful in a small number of cases.17 Intrave-
nous immunoglobulin, steroid, or thyrotrophin were used in
isolated case reports but remain unproven therapies.
The outcome of our patient was poor but recent series
showed better prognosis than previously thought. Singh
et al18 reported a mortality of approximately 25%, and
there was a trend of improvement of outcome in recent
years. More importantly, 52% of the survivors did not have
significant disability.18 Louis et al19 reported similar good
functional outcome, even among the most severely
affected individuals.
Osmotic demyelination syndrome may occur in perito-
neal dialysis patients with only mild hyponatremia and
without rapid correction. MRI is useful for diagnosis. The
outcome may be favorable in survivors.
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